Mumbai, February 17, 2025 – SMT, a global leader in cardiovascular medical devices, today announced the appointment of Mr. Bhargav Kotadia as its CEO and Mr. Jose Calle Gordo (‘Pepe’) as the Chairman effective April 1st 2025.

Mr. Bhargav Kotadia succeeds Mr. Ganesh Sabat, who has played an instrumental role in SMT’s growth journey over the past 12 years. Mr. Sabat’s leadership has been pivotal in expanding SMT’s global footprint, strengthening its innovation pipeline, and fostering a high-performance culture. The company expresses its deep gratitude for his dedication and contributions.

Mr. Dhirajlal Kotadia, SMT’s Founder and Chairman, will take on the role of Chairman Emeritus, continuing to provide strategic guidance while Mr. Jose Calle Gordo (‘Pepe’) will assume the role of Chairman, working closely with Mr. Kotadia to drive SMT’s next phase of growth.

Mr. Bhargav Kotadia has been closely associated with SMT’s strategic direction for last 12 years, playing a key role in shaping the company’s expansion and innovation agenda. Under his leadership, SMT will remain committed to its core values of Care, Innovation, Excellence and Agility, with a continued focus on advancing cardiovascular care globally.

“This marks an exciting new chapter for SMT,” said Mr. Jose Calle Gordo, incoming Chairman of SMT. “Bhargav’s deep understanding of the industry, combined with his strategic vision, will drive SMT’s continued growth and leadership in cardiovascular technologies. We remain committed to our mission of delivering high-quality, life-saving solutions to patients worldwide.”

“I am honored to take on this responsibility and build upon the incredible legacy of SMT”, said Mr. Bhargav Kotadia. “Our goal remains clear to innovate, expand, and make a meaningful impact in global cardiovascular care. I look forward to working with our talented team to achieve new milestones in the years ahead.”